APLASTIC ANEMIA
CONTENTS
INTRODUCTION
Figure 1:
Bone Marrow
CAUSES
Figure 2:Epstein Barr virus Figure 3: Parovirus
STATISTICS
SYMPTOMS
Figure 4:Red spots Figure 5:Bruise
LAB DIAGNOSIS
1. Complete blood count (CBC)
(a) low RBC, WBC, platelets
(b) low Hb and Ht level
2. Reticulocyte count
COMPONENT NORMAL VALUE
MALE FEMALE
RBC 4.7 – 6.1 mil cell/mcL 4.2 – 5.4 mil cell/mcL
Hemoglobin 13.8 – 17.2 gm/dL 12.1 – 15.1 gm/dL
Hematocrit 40.7 – 50.3 36.1 – 44.3
WBC 4500 – 10 000 cell/mcL
Platelet 150 000 - 400 000 /mcL
Reticulocyte 0.5 – 1.5%
3. Bone marrow test
(a) BM aspiration (fluid)
(b) BM biopsy (tissue)
4. Antibody test
5. Other test
a) Vitamin B12 & folate test
b) Liver test & viral test
c) X-ray, CT scan
d) ultrasound imaging test
Figure 6: BM Biopsy
TREATMENT
1. Stem cell transplant
2. Immunosuppressant
3. Blood transfusion
4. Bone marrow stimulant
5. Antibiotics & antiviral
Figure 7:Blood transfusion
PREVENTION
Avoid exposure to:
a) Insecticide
b) Herbicides
c) Organic solvents
d) Toxic chemical
Figure 8: Exposure to herbicides
CONCLUSION
Aplastic anemia - blood disorder that can be inherited or acquired
Serious problem - no enough oxygen supply in body
- infection
Treatment - medications, stem cell transplant & blood transfusion
Patients are advised to:
a)Take good rest when needed
b)Avoid contact sports
c)Be hygienic
CASE STUDY
1. Patient’s Detail
 46 years old male
 Hepatitis C virus (HCV) infection
 Combination treatment of PEG-IFN-a 2a (180 μg, weekly) and
ribavirin (1200 mg/day) was commenced for a period of 48 weeks
2. Symptoms
 Bleeding tendency
 Unexplained fatigue of recent onset
3. Physical Examination
 Generalized purpura and bruising, pallor of the skin and mucous
membranes
 The patient’s liver, spleen and lymph nodes- not enlarged
Figure 9: A bone marrow biopsy showing the absence of hematopoietic tissue
and its replacement with fat.
4. TREATMENT
 Allogeneic bone marrow transplantation after completing two
courses of immunosuppressive.
 Therapy with antithymocyte globulin and cyclosporin A.
REFERENCES
 Anonymous, (2012), What is aplastic anemia, Viewed on 8thth
February 2013, http://www.mayoclinic.com/health/risk -factors
 Anonymous, (2012), Diagnosis of aplastic anemia, Viewed on 8thth
February 2013, http://www.nhlbi.nih.gov/health-topics.html
 Anonymous, (2013), Aplastic anemia-info, Viewed on 8thth
February
2013, http://www.bodyandhealth.canada.com
 Anonymous, (2005), Causes of aplastic anemia, Viewed on 8thth
February 2013, http://www.childrenhospital.org
 David C., (2012), Idiopathic-aplastic anemia, Viewed on 8thth
February 2013, http://www.health.nytimes.com/health/guides.html
 Anonymous, (2008), Aplastic anemia, Viewed on 8thth
February
2013, http://www.uth.tmc.edu/pathology/medic.html
 Anonymous, (2012), Statistics of aplastic anemia, Viewed on 8thth
February 2013, http://www.aamds.org
 Anonymous, (2012), diagnosis, viewed on 8th
February 2013,
http://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/
 Anonymous, (2013), bone marrow biopsy, prevention, viewed on 8th
February 2013, http://www.mayoclinic.com/health/medical/IM01819
 Anonymous, (2011), CBC, viewed on 8th
February 2013,
http://www.aamds.org/about/blood-and-bone-marrow-basics/CBC
 Anonymous, (2013), treatment, prevention, viewed on 8th
February
2013, http://www.mayoclinic.com/health/aplastic-anemia/DS00322
 Anonymous, (2011), treatment, viewed on 8th
February 2013,
http://www.aamds.org/about/aplastic-anemia
 Ioannou, S., Hatzis, G., Vlahadami, I., Voulgarelis, M.(2010),Aplastic
anemia associated with interferon alpha 2a in a patient with chronic
hepatitis C virus infection: a case report. J Med Case Rep. 4(268)
Aplastic anemia

Aplastic anemia

  • 1.
  • 2.
  • 3.
  • 5.
  • 6.
  • 8.
    Figure 2:Epstein Barrvirus Figure 3: Parovirus
  • 9.
  • 10.
  • 12.
    Figure 4:Red spotsFigure 5:Bruise
  • 13.
    LAB DIAGNOSIS 1. Completeblood count (CBC) (a) low RBC, WBC, platelets (b) low Hb and Ht level 2. Reticulocyte count COMPONENT NORMAL VALUE MALE FEMALE RBC 4.7 – 6.1 mil cell/mcL 4.2 – 5.4 mil cell/mcL Hemoglobin 13.8 – 17.2 gm/dL 12.1 – 15.1 gm/dL Hematocrit 40.7 – 50.3 36.1 – 44.3 WBC 4500 – 10 000 cell/mcL Platelet 150 000 - 400 000 /mcL Reticulocyte 0.5 – 1.5%
  • 14.
    3. Bone marrowtest (a) BM aspiration (fluid) (b) BM biopsy (tissue) 4. Antibody test 5. Other test a) Vitamin B12 & folate test b) Liver test & viral test c) X-ray, CT scan d) ultrasound imaging test Figure 6: BM Biopsy
  • 15.
    TREATMENT 1. Stem celltransplant 2. Immunosuppressant 3. Blood transfusion 4. Bone marrow stimulant 5. Antibiotics & antiviral Figure 7:Blood transfusion
  • 16.
    PREVENTION Avoid exposure to: a)Insecticide b) Herbicides c) Organic solvents d) Toxic chemical Figure 8: Exposure to herbicides
  • 17.
    CONCLUSION Aplastic anemia -blood disorder that can be inherited or acquired Serious problem - no enough oxygen supply in body - infection Treatment - medications, stem cell transplant & blood transfusion Patients are advised to: a)Take good rest when needed b)Avoid contact sports c)Be hygienic
  • 18.
    CASE STUDY 1. Patient’sDetail  46 years old male  Hepatitis C virus (HCV) infection  Combination treatment of PEG-IFN-a 2a (180 μg, weekly) and ribavirin (1200 mg/day) was commenced for a period of 48 weeks 2. Symptoms  Bleeding tendency  Unexplained fatigue of recent onset
  • 19.
    3. Physical Examination Generalized purpura and bruising, pallor of the skin and mucous membranes  The patient’s liver, spleen and lymph nodes- not enlarged
  • 20.
    Figure 9: Abone marrow biopsy showing the absence of hematopoietic tissue and its replacement with fat.
  • 21.
    4. TREATMENT  Allogeneicbone marrow transplantation after completing two courses of immunosuppressive.  Therapy with antithymocyte globulin and cyclosporin A.
  • 22.
    REFERENCES  Anonymous, (2012),What is aplastic anemia, Viewed on 8thth February 2013, http://www.mayoclinic.com/health/risk -factors  Anonymous, (2012), Diagnosis of aplastic anemia, Viewed on 8thth February 2013, http://www.nhlbi.nih.gov/health-topics.html  Anonymous, (2013), Aplastic anemia-info, Viewed on 8thth February 2013, http://www.bodyandhealth.canada.com  Anonymous, (2005), Causes of aplastic anemia, Viewed on 8thth February 2013, http://www.childrenhospital.org  David C., (2012), Idiopathic-aplastic anemia, Viewed on 8thth February 2013, http://www.health.nytimes.com/health/guides.html
  • 23.
     Anonymous, (2008),Aplastic anemia, Viewed on 8thth February 2013, http://www.uth.tmc.edu/pathology/medic.html  Anonymous, (2012), Statistics of aplastic anemia, Viewed on 8thth February 2013, http://www.aamds.org  Anonymous, (2012), diagnosis, viewed on 8th February 2013, http://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/  Anonymous, (2013), bone marrow biopsy, prevention, viewed on 8th February 2013, http://www.mayoclinic.com/health/medical/IM01819  Anonymous, (2011), CBC, viewed on 8th February 2013, http://www.aamds.org/about/blood-and-bone-marrow-basics/CBC
  • 24.
     Anonymous, (2013),treatment, prevention, viewed on 8th February 2013, http://www.mayoclinic.com/health/aplastic-anemia/DS00322  Anonymous, (2011), treatment, viewed on 8th February 2013, http://www.aamds.org/about/aplastic-anemia  Ioannou, S., Hatzis, G., Vlahadami, I., Voulgarelis, M.(2010),Aplastic anemia associated with interferon alpha 2a in a patient with chronic hepatitis C virus infection: a case report. J Med Case Rep. 4(268)